E-LIB Suche - Ergebnisse für: Brody, Joshua

1

Society for Immunotherapy of Cancer (SITC) recommendations ..:

Luke, Jason J ; Davar, Diwakar ; Andtbacka, Robert H...
Journal for ImmunoTherapy of Cancer. 12 (2024) 4 - p. e008378 , 2024

Link: https://doi.org/10.1136/..

2

Brentuximab vedotin as a bridge to combination chemotherapy..:

Asrani, Roshan ; Cengiz, Turgot Bora ; Petersen, Bruce E...
Frontiers in Oncology. 13 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

3

Immunotherapy-resistant acute lymphoblastic leukemia cells ..:

Aminov, Sarah ; Giricz, Orsi ; Melnekoff, David T....
Journal of Clinical Investigation. 134 (2024) 8 - p. , 2024

Link: https://doi.org/10.1172/..

4

Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Ago..:

Tolcher, Anthony W. ; Brody, Joshua D. ; Rajakumaraswamy, Nishanthan...
Clinical Cancer Research. 30 (2024) 14 - p. 2954-2963 , 2024

Link: https://doi.org/10.1158/..

5

Results from the Epcore NHL-2 Trial Arm 8: Epcoritamab SC +..:

Vermaat, Joost S.P. ; Brody, Joshua ; Duras, Juraj...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S357-S358 , 2024

Link: https://doi.org/10.1016/..

6

High Complete Metabolic Response Rates with Epcoritamab SC ..:

Brody, Joshua ; Jørgensen, Judit ; Belada, David...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S357 , 2024

Link: https://doi.org/10.1016/..

7

Nivolumab plus brentuximab vedotin for relapsed/refractory ..:

Zinzani, Pier Luigi ; Salles, Gilles ; Moskowitz, Alison J....
Blood Advances. 8 (2024) 10 - p. 2400-2404 , 2024

Link: https://doi.org/10.1182/..

8

ABCL-429 Epcoritamab + R-CHOP in Patients With Previously U..:

Falchi, Lorenzo ; Clausen, Michael Roost ; Offner, Fritz...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S431-S432 , 2023

Link: https://doi.org/10.1016/..

9

Pattern recognition receptor agonists in pathogen vaccines ..:

Aleynick, Mark ; Svensson-Arvelund, Judit ; Pantsulaia, Gvantsa...
Journal for ImmunoTherapy of Cancer. 11 (2023) 7 - p. e007198 , 2023

Link: https://doi.org/10.1136/..

10

P1129: GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REF..:

Hutchings, Martin ; Carlo-Stella, Carmelo ; Morschhauser, Franck...
HemaSphere. 7 (2023) S3 - p. e458981a , 2023

Link: https://doi.org/10.1097/..

11

S235: GENERATION AND APPLICATION OF A LIVING T-CELL LYMPHOM..:

Cappelli, Luca Vincenzo ; Fiore, Danilo ; Zhaoqi, Liu...
HemaSphere. 7 (2023) S3 - p. e58193ee , 2023

Link: https://doi.org/10.1097/..

12

P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITA..:

Roost Clausen, Michael ; Belada, David ; Offner, Fritz...
HemaSphere. 7 (2023) S3 - p. e55140cd , 2023

Link: https://doi.org/10.1097/..

13

POSTER: ABCL-429 Epcoritamab + R-CHOP in Patients With Prev..:

Falchi, Lorenzo ; Clausen, Michael Roost ; Offner, Fritz...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S205 , 2023

Link: https://doi.org/10.1016/..

14

Perspectives in Immunotherapy: meeting report from Immunoth..:

Ascierto, Paolo A. ; Avallone, Antonio ; Bifulco, Carlo...
Journal of Translational Medicine. 21 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

15

P1205: A LIVING PATIENT-DERIVED BIOREPOSITORY FOSTERING MIC..:

Fiore, Danilo ; Vincenzo Cappelli, Luca ; Zhaoqi, Liu...
HemaSphere. 7 (2023) S3 - p. e8686389 , 2023

Link: https://doi.org/10.1097/..